ε-Viniferin, a resveratrol dimer, prevents diet-induced obesity in mice
- Biochem Biophys Res Commun. 2015 Dec 25;468(4):877-82. doi: 10.1016/j.bbrc.2015.11.047.
- 1. Kirin Company, Limited, Research Laboratories for Health Science and Food Technologies, Research and Development Division, 1-13-5, Fukuura Kanazawa-ku, Yokohama 236-0004, Japan. Electronic address: [email protected].
- 2. Kirin Company, Limited, Research Laboratories for Health Science and Food Technologies, Research and Development Division, 1-13-5, Fukuura Kanazawa-ku, Yokohama 236-0004, Japan.
- 3. Mercian Corporation, New Product & Process Developments, 4-9-1 Johnan, Fujisawa, Kanagawa 251-0057, Japan.
Red wines are thought to be one of the major dietary sources of trans-resveratrol. The beneficial effects of t-resveratrol against metabolic disorders have been well characterized, however, red wines also contain various resveratrol derivatives whose health benefits have not been completely elucidated. In this report, we investigated ε-viniferin, a resveratrol dimer, which is present at comparable concentrations to t-resveratrol in red wines, and has higher anti-adipogenesis activity in 3T3-L1 cells. In addition, ε-viniferin was more effective than t-resveratrol in its anti-obesity and anti-inflammatory effects in high-fat diet fed mice. These results suggested ε-viniferin may be one of the active ingredients against metabolic disorders in red wines, in addition to t-resveratrol.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Cytochrome P450
-